Xanthine oxidoreductase-IN-4

Modify Date: 2024-04-07 00:32:32

Xanthine oxidoreductase-IN-4 Structure
Xanthine oxidoreductase-IN-4 structure
Common Name Xanthine oxidoreductase-IN-4
CAS Number 1026587-58-5 Molecular Weight 309.32
Density N/A Boiling Point N/A
Molecular Formula C16H15N5O2 Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Xanthine oxidoreductase-IN-4


Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor. Xanthine oxidoreductase-IN-4 has inhibitory activity against XOR with an IC50 value of 29.3 nM. Xanthine oxidoreductase-IN-4 can be used for the research of hyperuricemia[1].

 Names

Name Xanthine oxidoreductase-IN-4

 Xanthine oxidoreductase-IN-4 Biological Activity

Description Xanthine oxidoreductase-IN-4 is an orally active xanthine oxidoreductase (XOR) inhibitor. Xanthine oxidoreductase-IN-4 has inhibitory activity against XOR with an IC50 value of 29.3 nM. Xanthine oxidoreductase-IN-4 can be used for the research of hyperuricemia[1].
Related Catalog
Target

IC50: 29.3 nM (XOR)[1]

In Vitro Xanthine oxidoreductase-IN-4 (Compound IIIc) 对 XOR 具有抑制活性,IC50 值为 29.3 nM[1]。
In Vivo Xanthine oxidoreductase-IN-4 (Compound IIIc) (oral; 5 mg/kg)在恶嗪酸钾/次黄嘌呤诱导的急性高尿酸血症模型中显示出显着的低尿酸血症效应[1]。 Animal Model: Mice acute hyperuricemia model[1] Dosage: 5 mg/kg Administration: Oral Result: Reduced serum levels of uric acid significantly from 4 h after administration.
References

[1]. Wen Peng, et al. Design, synthesis, and evaluation of tricyclic compounds containing phenyl-tetrazole as XOR inhibitors. Eur J Med Chem. 2022 Nov 28;246:114947.  

 Chemical & Physical Properties

Molecular Formula C16H15N5O2
Molecular Weight 309.32